SMTL ID : 6nov.2 (1 other biounit)

A Fab derived from ixekizumab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.14 Å

Oligo State

hetero-1-1-mer

Ligands

None

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH

Citation

Benschop, R.J. et al., Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. Mabs (2019)

Release Date

2019-06-19

Peptides

Fab Heavy Chain: A
Fab Light Chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Fab Heavy Chain

Fab Light Chain

Related Entries With Identical Sequence